ACA Plans Denied 19% Of In-Network Claims In 2024: Report

Health insurance exchange carriers rejected nearly one-in-five in-network claims in 2024.

That’s according to federal health insurance exchange claims data analyzed by the health policy research institute KFF. The 19% denial rate is tied with 2023 for the highest since the Affordable Care Act of 2010 marketplaces debuted in 2015.

Oscar Health, Molina Healthcare, Florida Blue, Community Health Choice, Cigna and BlueCross BlueShield of Tennessee turned down the largest share of in-network claims for plans purchased on the federal enrollment platform, KFF reported Tuesday.

The denial rate has held steady over time, dipping to a low of 14% in 2018.

​The KFF report does not include 20 states and the District of Columbia, which operate their own health insurance exchanges and manage enrollments. The analysis is limited to insurers that processed at least 1,000 claims in 2024 and still participate in the federal enrollment system.

Oscar Health rejected the greatest share of in-network federal exchange plan claims in 2024. Its denial rate jumped from 17% in 2023 to 25% in 2024.

Molina Healthcare came in second despite its denial rate declining from 26% in 2023 to 22% in 2024. Florida Blue, Community One Choice, BlueCross BlueShield of Tennessee and Cigna each refused at last 20% of these claims.

UnitedHealth Group subsidiary UnitedHealthcare approves 98% of complete claims for eligible members, the company said in a statement. None of the other insurers responded to interview requests.

“Health plans approve the overwhelming majority of claims they receive,” the trade group AHIP said in a statement. “The vast majority of denials are due to incorrect or incomplete claim submissions from providers, duplicate claims, claims for unproven or unsafe treatments and services, or for services that are not part of covered benefits. An appeal is always available.”

Members appealed fewer than 1% of denials, and insurers stood by their original decisions in 66% of challenges, according to KFF.

The rate of in-network denials was steady across metal levels. Insurers turned down the most in-network claims, or 22%, for catastrophic plans and the least, or 17%, for Gold coverage.

There was a wide range from state to state. South Dakota and New Hampshire insurers rejected 7% of in-network claims, the fewest, while Hawaii carriers declined 27%, the most.

Health insurance companies cited medical necessity or benefit limits in 5% of in-network denials, KFF found. They cited administrative reasons for 25%, excluded services for 13%, lack of prior authorization for 9% and member not covered for 7%. The most common reason they reported was “other,” at 36%.

Last year, the industry groups AHIP, the Blue Cross Blue Shield Association and more than 40 insurance companies committed to reduce the prior authorization burden and to communicate more about denials. The industry pledge followed a federal regulation that set similar requirements for prior authorizations under government health programs.

 

Source Link

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square